Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000912282-25-000223
Filing Date
2025-03-03
Accepted
2025-03-03 19:22:47
Documents
1
Period of Report
2025-02-05

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 5147
  Complete submission text file 0000912282-25-000223.txt   6850
Mailing Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237
Business Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237 (720) 437-6580
AYTU BIOPHARMA, INC (Issuer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 4275 EXECUTIVE SQUARE SUITE 650 LA JOLLA CA 92037
Business Address
Selhorn Ryan J (Reporting) CIK: 0001670673 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38247 | Film No.: 25700792